Chronic Kidney Disease Requiring Chronic Dialysis
52
10
10
31
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 52 trials
100.0%
+13.5% vs benchmark
17%
9 trials in Phase 3/4
23%
7 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 31 completed trials
Clinical Trials (52)
Fluid Intake After Hemodialysis
Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination
Evaluation of Routinely Measured Patient-reported Outcomes in Hemodialysis Care
Advance Care Planning in the Emergency Department
The Intravenous Amino Acid Therapy for Vascular Rigidity in End Stage Renal Disease
Impact of Dialysis on Sexuality.
Therapeutic Effects of Press Needle on 5-D Pruritus Scale in Hemodialysis Patients With Chronic Kidney Disease-Associated Pruritus
DIALysis With EXpanded Solute Removal
Smart and Fit for Kidney Transplantation
Effect of Viscous Fiber on Postprandial Kalemic Response in Hemodialysis Patients
A Study to Compare Efficacy and Safety of Nanogen's Darbepoetin Alfa With Aranesp® (Amgen) in the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis (CKD)
Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients
Immuno-nutrition Supplementation in Haemodialysis
Orthostatic Hypotension and Blood Pressure Variability in Persons Undergoing Hemodialysis
Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation
Lumasiran in Hyperoxalaemic Patients on Haemodialysis
A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis
High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers
Modulation of Tissue Sodium in Hemodialysis Patients
Pathways Project: Kidney Supportive Care